Source: International Congress 2014 – Systemic and airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Rovina, E. Dima, P. Bakakos, E. Tseliou, K. Kontogianni, S. Papiris, N. Koulouris, S. Loukides (Athens, Greece). Implication of IL-18 in the chronic inflammation of severe refractory asthma. Eur Respir J 2014; 44: Suppl. 58, 2042

Member's Comments

No comment yet.

Related content which might interest you: Obesity influences inflammatory phenotype mainly in early onset severe asthmatics Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Treating peripheral eosinophilia in asthma: Simple and effective Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Oxidative stress and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Interleukin-33 and Th2 cytokines correlate in acute asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Associated factors with persistent airflow limitation in asthma in U-BIOPRED Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Relation of hemogram parameters with asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Airway remodeling and eosinophilic asthma Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016